TABLE 3.
Characteristic | OS (Log-rank P) | DSS (Log-rank P) |
---|---|---|
Age at diagnosis | <0.001 | <0.001 |
Race/Ethnicity | ||
White vs. Black | 0.031 | 0.026 |
Black vs. Other | 0.113 | 0.078 |
White vs. Other | 0.703 | 0.604 |
Sex | 0.073 | 0.065 |
Decade of diagnosis | 0.100 | 0.146 |
Tumor grade | <0.001 | <0.001 |
Subtypes | ||
NOS vs. myxoid | 0.356 | 0.302 |
NOS vs. mesenchymal | 0.074 | 0.003 |
NOS vs. dedifferentiated | 0.001 | <0.001 |
Myxoid vs. mesenchymal | 0.203 | 0.044 |
Myxoid vs. dedifferentiated | 0.004 | 0.001 |
Mesenchymal vs. dedifferentiated | 0.725 | 0.836 |
Surgical resection | <0.001 | <0.001 |
Radiation therapy performed | <0.001 | <0.001 |
Treatment modality | <0.001 | <0.001 |
Surgery + radiation vs. surgery only | <0.001 | <0.001 |
Surgery + radiation vs. radiation only | <0.001 | <0.001 |
Surgery + radiation vs. no therapy | <0.001 | 0.001 |
Surgery vs. radiation only | <0.001 | <0.001 |
Surgery vs. no therapy | <0.001 | <0.001 |
Radiation vs. no therapy | <0.001 | 0.659 |
Extent of disease | <0.001 | <0.001 |
Size (cm) | <0.001 | <0.001 |
DSS indicates disease-specific survival; OS, overall survival.